Study on maternal and perinatal outcome in ORAL HYDRATION THERAPY WITH ORS VERSUS NO HYDRATION THERAPY in term pregnancies with isolated oligohydramnios

A comparitive Study on maternal and perinatal outcome in ORAL HYDRATION THERAPY WITH ORS VERSUS NO HYDRATION THERAPY in term pregnancies with isolated oligohydramnios - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075111

Enrollment

Registered

2024-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Oral hydration therapy: GROUP 1- 37-40Weeks gestation,oligohydramnios with ORS Therapy GROUP 2-37-40weeks,oligohydramnios no hydration therapy umbilical cord artery ph values is observe

Eligibility

Inclusion criteria

Inclusion criteria: singleton pregnancies under cephalic presentation between gestational age of 37-40weeks with isolated oligohydramnios

Exclusion criteria

Exclusion criteria: Hypertensive disorder of pregnancy PROM Gestational diabetes mellitus IUGR Congenital malformations IUD

Design outcomes

Secondary

Measure	Time frame
Intrapartum events such as fetal distress,mode of delivery,neonatal outcome with respect to apgar scoreTimepoint: 4weeks	—

Primary

Measure	Time frame
To observe the maternal and perinatal outcome of oral hydration therapy on outcome of pregnancies complicated by moderate oligohydramniosTimepoint: 4weeks	—

Countries

India

Contacts

Public ContactDr Rajasri yaliwal

SHRI B M PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTER

ryaliwal@gmail.com9845152240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026